U.S. Representative,

U.S. Congress

President & CEO,

Lyndra

Founding CEO,

DaCapo Brainscience

Head of Global Dis. Bus. Dev.,

Evotec

Managing Director,

Vertex Ventures HC

Senior Vice President,

CRISPR Therapeutics

CEO,

Rapport Therapeutis

Co-Founder, eGenesis;

Prof. of Genetics, HMS

VP, Comms & Inv. Rels,

Third Rock Ventures

Associate Chief Legal Officer,

Mayo Clinic

CEO,

CBT Advisors

Managing Director,

JRDF T1D Fund

Chief Medical Officer,

Alnylam Pharmaceuticals

CEO,

Arrakis Therapeutics

Secretary of Economic Dev.,

Commonwealth of MA

Managing Director,

Brain Tumor Investment Fund

CEO, Aitia

Founding Director,

Wyss Institute

General Partner.

Section 32

President & CEO,

ROME Therapeutics

Distinguished Professor,

Brigham and Women’s Hospital

CEO and co-founder,

POLARISqb

CEO,

Nimbus Therapeutics

Managing Director,

GrayBella Capital

Managing Partner,

RA Capital Management

Managing Partner,

MacDougall

CEO and President,

Vigil Neuroscience

President, Biomedical Research,

Novartis

Chief Innovation Officer,

Halloran Consulting Group

Atlas Ventures Advisor,

Acting CEO Q32

Johnson & Johnson Innov.

- JJDC

Executive Partner,

Polaris Partners

Managing Director,

Myeloma Investment Fund

President & CEO,

Editas

Chief Commercial Officer,

Owkin

EVP, Chief Research Officer,

Bristol Myers Squibb

Managing Director,

BrightEdge - American Cancer Society

Board of Directors,

Mersana Therapeutics

Partner,

Third Rock Ventures

Sr. Managing Director,

Blackstone Life Sciences

Partner,

WilmerHale

Chief Data Scientist,

Orionis Biosciences

CEO,

Psivant Therapeutics

President/CEO,

South Shore Health

Executive Director,

Incubate Coalition

Chief Clin. Trials Off.,

Walgreens Boots Alliance

Director and Trustee,

Healthcare, Life Sci. & Financial Svs

Principal, Venture Invest.,

The Mark Foundation

Partner,

Foley and Lardner, LLP

Managing Director,

NYBC Ventures